Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 07, 2026
DataAggregated Company Financials
Companies5
  • 7D3.5%
  • 3M-17.9%
  • 1Y24.4%
  • YTD-15.5%

Over the last 7 days, the Biotech industry has risen 4.1%, driven by gains from every company within the industry. This takes the industry's 12 month performance to a gain of 22%. Earnings are forecast to grow by 1.8% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 07 Apr 2026DKK 144.6bDKK 39.6bDKK 14.0b11x10.3x3.6x
Thu, 05 Mar 2026DKK 151.6bDKK 40.0bDKK 15.0b6x10.1x3.8x
Sat, 31 Jan 2026DKK 169.6bDKK 40.2bDKK 18.8b6.1x9x4.2x
Mon, 29 Dec 2025DKK 180.1bDKK 40.5bDKK 18.9b6.1x9.5x4.4x
Wed, 26 Nov 2025DKK 174.8bDKK 40.9bDKK 19.1b5.9x9.1x4.3x
Fri, 24 Oct 2025DKK 171.5bDKK 39.1bDKK 16.8b13.3x10.2x4.4x
Sun, 21 Sep 2025DKK 162.9bDKK 38.8bDKK 16.7b12.7x9.7x4.2x
Tue, 19 Aug 2025DKK 139.8bDKK 38.7bDKK 16.7b10.6x8.4x3.6x
Thu, 17 Jul 2025DKK 127.3bDKK 27.0bDKK 7.4b11.3x17.3x4.7x
Sat, 14 Jun 2025DKK 138.2bDKK 27.2bDKK 7.4b11.6x18.7x5.1x
Mon, 12 May 2025DKK 125.9bDKK 28.0bDKK 7.9b10.1x15.9x4.5x
Wed, 09 Apr 2025DKK 124.1bDKK 27.3bDKK 7.7b11x16.1x4.5x
Fri, 07 Mar 2025DKK 156.8bDKK 27.3bDKK 7.7b13.2x20.4x5.7x
Sun, 02 Feb 2025DKK 158.5bDKK 26.0bDKK 4.7b16.5x33.8x6.1x
Tue, 31 Dec 2024DKK 160.9bDKK 26.0bDKK 4.7b16.7x34.3x6.2x
Thu, 28 Nov 2024DKK 161.6bDKK 26.0bDKK 4.7b16.7x34.4x6.2x
Sat, 26 Oct 2024DKK 179.0bDKK 25.5bDKK 5.5b21.3x32.7x7x
Mon, 23 Sep 2024DKK 191.9bDKK 25.5bDKK 5.5b23.3x35.1x7.5x
Wed, 21 Aug 2024DKK 200.6bDKK 26.1bDKK 5.7b21x35x7.7x
Fri, 19 Jul 2024DKK 193.1bDKK 24.8bDKK 5.6b18.2x34.3x7.8x
Sun, 16 Jun 2024DKK 172.3bDKK 24.8bDKK 5.6b17.2x30.6x6.9x
Tue, 14 May 2024DKK 180.7bDKK 24.8bDKK 5.7b18.3x31.9x7.3x
Thu, 11 Apr 2024DKK 186.2bDKK 23.9bDKK 5.0b19.6x36.9x7.8x
Sat, 09 Mar 2024DKK 193.7bDKK 23.9bDKK 5.0b19.9x38.5x8.1x
Mon, 05 Feb 2024DKK 166.2bDKK 23.3bDKK 4.2b22.8x39.9x7.1x
Wed, 03 Jan 2024DKK 177.7bDKK 23.3bDKK 4.2b26.3x42.7x7.6x
Fri, 01 Dec 2023DKK 174.6bDKK 23.3bDKK 4.2b25.4x41.9x7.5x
Sun, 29 Oct 2023DKK 158.4bDKK 22.0bDKK 4.7b18.5x33.4x7.2x
Tue, 26 Sep 2023DKK 195.9bDKK 22.0bDKK 4.7b23x41.4x8.9x
Thu, 24 Aug 2023DKK 196.3bDKK 22.0bDKK 4.7b23.4x41.6x8.9x
Sat, 22 Jul 2023DKK 211.1bDKK 19.5bDKK 4.4b41.8x47.9x10.8x
Mon, 19 Jun 2023DKK 208.1bDKK 19.5bDKK 4.4b44x47.2x10.6x
Wed, 17 May 2023DKK 217.6bDKK 17.9bDKK 4.0b33.6x54.4x12.2x
Fri, 14 Apr 2023DKK 207.1bDKK 17.9bDKK 3.5b32.3x58.6x11.6x
Price to Earnings Ratio

58.6x


Total Market Cap: DKK 207.1bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 29.3x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.3x which is lower than its 3-year average PE of 29.3x.
  • The 3-year average PS ratio of 6.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market2.52%
Healthcare2.60%
Biotech3.47%
Biotech3.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.76k4.1%
+DKK 4.3b		42.5%PE17.3x
ZEAL Zealand PharmaDKK 298.001.4%
+DKK 282.5m		-27.4%PE3.3x
BAVA Bavarian NordicDKK 195.701.7%
+DKK 254.8m		39.6%PE11x
BIOPOR BioPortoDKK 0.893.4%
+DKK 14.4m		-33.7%PS10.9x
STRAP Strategic PartnersDKK 608.004.8%
+DKK 1.2m		-31.7%PS82.1x

Latest News

STRAP
DKK 608.00
Strategic Partners
7D
4.8%
1Y
-31.7%
BIOPOR
DKK 0.89
BioPorto
7D
3.4%
1Y
-33.7%
BAVA
DKK 195.70
Bavarian Nordic
7D
1.7%
1Y
39.6%

BAVA: Expanded Vaccine Pipeline And New Contracts Will Support Higher Future Returns

Analysts have raised their price target on Bavarian Nordic from DKK 244.00 to DKK 280.00. They cite updated assumptions for revenue growth, profit margins, and a lower future P/E multiple that they view as better reflecting the company’s current outlook.
GMAB
DKK 1,758.50
Genmab
7D
4.1%
1Y
42.5%

GMAB: 2026 Late Stage Oncology Catalysts Will Support Stronger Margin Profile

Genmab's updated analyst price target now sits at DKK 3,017, a modest reset from DKK 3,060 as analysts factor in higher discount rates, revised long term margin expectations, and recent research that reflects both increased revenue growth assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research around Genmab has centered on how new clinical and portfolio developments filter into valuation, with several bullish analysts updating price targets and investment cases to reflect revised expectations on execution and long term growth potential.
ZEAL
DKK 298.00
Zealand Pharma
7D
1.4%
1Y
-27.4%